Evidence map›Paper›PMID 40351830›Full record

ArticleNeuro-oncology advances

Multidisciplinary adolescent and young adult neuro-oncology clinic: Clinical cases, practice challenges, and future perspectives.

Christianne V Mojica, Thiago Pimentel Muniz, Xin Wang, Stephanie Baker, Kim Edelstein, Cheryl Kanter, Katherine Mileski, Candice Nguyen, Angela Sekely, Derek S Tsang and 4 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Christianne V MojicaDepartment of Medicine, Division of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0001-6628-1480
Thiago Pimentel MunizDepartment of Medicine, Division Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Xin WangDepartment of Medicine, Division Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0001-6292-3087
Stephanie BakerCancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Kim EdelsteinDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-2648-4819
Cheryl KanterDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Katherine MileskiPencer Brain Tumor Centre, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Candice NguyenClinical Nutrition Department, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Angela SekelyDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5823-4294
Derek S TsangRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Cynthia HawkinsDivision of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-2618-4402
Uri TaboriDivision of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5019-2683
Warren P MasonDepartment of Medicine, Division of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Julie BennettDivision of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-4146-1511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The distinct tumor histopathology, molecular features, and psychosocial needs among adolescents and young adults (AYA) with brain tumors pose challenges within traditional healthcare systems. Establishing a multidisciplinary AYA neuro-oncology clinic has been proposed to address these gaps in care. This is the first study to describe the framework and patient profile of a multidisciplinary AYA neuro-oncology clinic in a quaternary cancer center in Canada. Methods: Clinic framework was outlined and patients seen from December 2022 to June 2024 were included. Demographic profiles, tumor characteristics, treatment details, clinical trial enrollment, and allied health referrals were collected. Barriers encountered were summarized. Results: The clinic is composed of specialists in pediatric and adult neuro-oncology with seamless referrals to neurosurgery, radiation oncology, and allied health teams. A total of 100 patients (males 54%, females 46%) were seen with a median age of 24 years. Pediatric-type low-grade glioma (PLGG) was the leading diagnosis. BRAF alterations were the primary molecular drivers. Twenty-nine patients received active neuro-oncology management in the clinic. Overall, 77 patients underwent at least one surgery, 31 patients received radiotherapy, and 43 patients received chemotherapy. Trametinib was the primary targeted treatment prescribed. Three patients were eligible and enrolled in clinical trials. Barriers identified included a lack of peer support groups and a paucity of available clinical trials. Conclusions: This study provides insight into the clinical profile of patients seen in a multidisciplinary AYA neuro-oncology clinic in Canada. Multidisciplinary care is feasible and integral in addressing the multifaceted needs of AYAs with brain tumors.

Indexed as

AYAmultidisciplinary careneuro-oncology

Identifiers

PMID40351830
PMCPMC12063081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.